Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UNC-CA359 is a highly potent inhibitor of the epidermal growth factor receptor (EGFR), demonstrating an IC50 value of 18 nM. With strong anti-tumor activity, UNC-CA359 holds significant potential for chordoma research [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | UNC-CA359 is a highly potent inhibitor of the epidermal growth factor receptor (EGFR), demonstrating an IC50 value of 18 nM. With strong anti-tumor activity, UNC-CA359 holds significant potential for chordoma research [1]. |
In vitro | UNC-CA359, also referred to as compound 45, demonstrates varying levels of activity across different targets: it is ineffective against U-CH1, partially effective on U-CH2, and strongly inhibits EGFR with IC50 values of >100 μM, 35 μM, and 18 nM, respectively. When tested in chordoma cell lines for 72 hours at concentrations ranging from 1 nM to 0.1 mM, UNC-CA359 exhibits IC50 values of 1.2 μM in CH22 and 3.0 μM in U-CH12 cells. Furthermore, it targets three collateral kinases, showing notable potency towards SLK/STK10 with a selectivity ratio over NAK of 22. The binding constants (Ki) for GAK, SLK, and STK10 are 3.4 nM, 0.33 μM, and 0.075 μM, respectively. In a cytotoxicity assay involving various chordoma cell lines and WS1 cells, it showed promising activity against the chordoma cells with IC50 values of 1.2 μM (CH22), 3.0 μM (U-CH12), 60 μM (UM-Chor1), and 74 μM (U-CH7), while exhibiting no toxicity toward WS1 cells (IC50 >100 μM). |
分子量 | 339.78 |
分子式 | C18H14ClN3O2 |
CAS No. | 2676156-05-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
UNC-CA359 2676156-05-9 Inhibitor inhibitor inhibit